- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01569945
Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur
September 9, 2014 updated by: Thomas D'Hooghe, University Hospital, Gasthuisberg
What is the best medication for hormonal stimulation in cycles with high intra-uterine insemination: tablets of Clomifen (5 days) followed by tablets of Ethinyl Estradiol (5 days) or daily injections with Human Menopausal Gonadotropin (Menopur)?
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
371
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vlaams Brabant
-
Leuven, Vlaams Brabant, Belgium, 3000
- Leuven University Fertility Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- women younger than 42 years old
- infertility of at least one year
- normal tubal, pelvic and uterine anatomy
- semen with total motility count of at least 5 million (at least one sample)
Exclusion Criteria:
- premature ovarian failure
- medical history of tubal or ovarian surgery
- tubal or pelvic adhesions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Tablets
Clomifen (5 days) followed by Ethinyl Estradiol (5 days)
|
starting on day 2 or 3 of the cycle: 1 tablet of Clomifen each day, for 5 days in a row.
Dose 50mg or in subsequent cycles, 25 mg or 100 mg or 150 mg.
After the 5 days of Clomifen, one tablet of Ethinyl Estradiol 50 mg per day, for 5 days in a row or until beta hCG is injected
|
Active Comparator: human menopausal gonadotropins
Daily Injections
|
Starting on day 2 or 3 of the cycle, a daily subcutaneous injection of 37.5 IU or 75.0 IU
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
pregnancy rate
Time Frame: on average 30 days if not pregnant and 12 weeks if pregnant
|
on average 30 days if not pregnant and 12 weeks if pregnant
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Thomas D'Hooghe, MD PhD, University Hospital, Gasthuisberg
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2004
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
March 28, 2012
First Submitted That Met QC Criteria
March 30, 2012
First Posted (Estimate)
April 3, 2012
Study Record Updates
Last Update Posted (Estimate)
September 10, 2014
Last Update Submitted That Met QC Criteria
September 9, 2014
Last Verified
September 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Infertility
- Physiological Effects of Drugs
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Estrogens
- Hormone Antagonists
- Estrogen Antagonists
- Contraceptive Agents, Hormonal
- Contraceptive Agents
- Reproductive Control Agents
- Contraceptives, Oral
- Contraceptive Agents, Female
- Fertility Agents, Female
- Fertility Agents
- Contraceptives, Oral, Hormonal
- Selective Estrogen Receptor Modulators
- Estrogen Receptor Modulators
- Estradiol
- Ethinyl Estradiol
- Menotropins
- Clomiphene
Other Study ID Numbers
- ML2436 - 1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Subfertility
-
University of NottinghamRecruitingInfertility, SubfertilityUnited Kingdom
-
University Hospital Schleswig-HolsteinCompletedInfertility, SubfertilityNorway, Germany
-
Australian Concept Medical CenterCompletedSubfertility, Female
-
University of Roma La SapienzaCompletedFemale Infertility | Female Subfertility
-
Turgut AydınRecruitingSubfertility, Female | Ovulation DisorderTurkey
-
Navy General Hospital, BeijingUnknownSubfertility, Female | Ovulation DisorderChina
-
Azienda Ospedaliera Città della Salute e della...UnknownOligospermia | Male Subfertility | Teratospermia | AsthenospermiaItaly
-
Infertility Treatment Center DortmundFerring Pharmaceuticals; TU Dortmund UniversityCompletedEnvironmental Exposure to Harmful Algae and Toxins | Female SubfertilityGermany
-
Radboud University Medical CenterGoodlife Fertility B.V.Active, not recruitingMale SubfertilityNetherlands
-
Ain Shams UniversityUnknownSubfertility, FemaleEgypt
Clinical Trials on Clomifen, Ethinyl Estradiol
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedOral Contraceptive | HemostasisGermany, Israel, Italy, Spain
-
NewAmsterdam PharmaNovumRecruitingHealthy VolunteersUnited States
-
Teva Pharmaceuticals USACompletedHealthyUnited States
-
Ortho-McNeil Janssen Scientific Affairs, LLCCompleted
-
University of OuluCompleted
-
Teva Pharmaceuticals USACompletedHealthyUnited States
-
Oregon Health and Science UniversityNational Institutes of Health (NIH); Oregon Clinical and Translational Research...Completed
-
The Jones InstituteUnknownPostpartum Depressive Mood | Postpartum Sexual FunctionUnited States
-
The Hospital for Sick ChildrenThe Physicians' Services Incorporated FoundationUnknown
-
Laboratorios Andromaco S.A.CompletedTherapeutic EquivalencyIndia